BioMérieux Vitek AST Kit Recall Given FDA Class I Treatment
The recall details that the affected kits contain incorrect concentrations of Ceftriaxone antibiotic in two wells.
The recall details that the affected kits contain incorrect concentrations of Ceftriaxone antibiotic in two wells.